Andrew Mok
Stock Analyst at Barclays
(2.65)
# 2,057
Out of 4,876 analysts
183
Total ratings
53.17%
Success rate
-0.07%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Equal-Weight | $273 → $268 | $240.20 | +11.57% | 10 | Jun 12, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $351 → $347 | $293.69 | +18.15% | 7 | Jun 9, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $362 → $350 | $305.70 | +14.49% | 10 | Jun 2, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $171 → $215 | $175.64 | +22.41% | 13 | Jun 2, 2025 | |
| HCA HCA Healthcare | Maintains: Overweight | $366 → $416 | $382.14 | +8.86% | 10 | Jun 2, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $522 → $480 | $376.96 | +27.33% | 8 | Jun 2, 2025 | |
| CVS CVS Health | Maintains: Overweight | $82 → $79 | $68.41 | +15.48% | 9 | Jun 2, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $382 → $385 | $330.21 | +16.59% | 6 | Jun 2, 2025 | |
| CNC Centene | Downgrades: Equal-Weight | $84 → $65 | $53.77 | +20.89% | 8 | Jun 2, 2025 | |
| SGRY Surgery Partners | Maintains: Equal-Weight | $25 → $24 | $21.93 | +9.44% | 2 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $23 → $24 | $22.00 | +9.09% | 8 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $35 → $28 | $21.74 | +28.79% | 13 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $3 | $2.29 | +31.00% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $249 → $257 | $180.85 | +42.11% | 22 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $117 → $130 | $122.34 | +6.26% | 16 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $36 | $24.99 | +44.09% | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $60 | $57.98 | +3.48% | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $9 | $13.74 | -34.50% | 4 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $4 | $3.49 | +14.78% | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $164 → $169 | $142.97 | +18.21% | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $116.08 | -28.49% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $9.56 | +25.52% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $98.09 | -3.15% | 7 | Aug 2, 2022 |
Humana
Jun 12, 2025
Maintains: Equal-Weight
Price Target: $273 → $268
Current: $240.20
Upside: +11.57%
Molina Healthcare
Jun 9, 2025
Maintains: Equal-Weight
Price Target: $351 → $347
Current: $293.69
Upside: +18.15%
UnitedHealth Group
Jun 2, 2025
Maintains: Overweight
Price Target: $362 → $350
Current: $305.70
Upside: +14.49%
Tenet Healthcare
Jun 2, 2025
Maintains: Overweight
Price Target: $171 → $215
Current: $175.64
Upside: +22.41%
HCA Healthcare
Jun 2, 2025
Maintains: Overweight
Price Target: $366 → $416
Current: $382.14
Upside: +8.86%
Elevance Health
Jun 2, 2025
Maintains: Overweight
Price Target: $522 → $480
Current: $376.96
Upside: +27.33%
CVS Health
Jun 2, 2025
Maintains: Overweight
Price Target: $82 → $79
Current: $68.41
Upside: +15.48%
The Cigna Group
Jun 2, 2025
Maintains: Overweight
Price Target: $382 → $385
Current: $330.21
Upside: +16.59%
Centene
Jun 2, 2025
Downgrades: Equal-Weight
Price Target: $84 → $65
Current: $53.77
Upside: +20.89%
Surgery Partners
May 27, 2025
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $21.93
Upside: +9.44%
May 27, 2025
Maintains: Equal-Weight
Price Target: $23 → $24
Current: $22.00
Upside: +9.09%
May 14, 2025
Maintains: Equal-Weight
Price Target: $35 → $28
Current: $21.74
Upside: +28.79%
May 8, 2025
Maintains: Underweight
Price Target: $2 → $3
Current: $2.29
Upside: +31.00%
Apr 29, 2025
Maintains: Overweight
Price Target: $249 → $257
Current: $180.85
Upside: +42.11%
Apr 28, 2025
Maintains: Buy
Price Target: $117 → $130
Current: $122.34
Upside: +6.26%
Apr 1, 2025
Initiates: Equal-Weight
Price Target: $36
Current: $24.99
Upside: +44.09%
Mar 24, 2025
Maintains: Overweight
Price Target: $74 → $60
Current: $57.98
Upside: +3.48%
Feb 28, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $13.74
Upside: -34.50%
Feb 20, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $3.49
Upside: +14.78%
Feb 18, 2025
Maintains: Equal-Weight
Price Target: $164 → $169
Current: $142.97
Upside: +18.21%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $116.08
Upside: -28.49%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $9.56
Upside: +25.52%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $98.09
Upside: -3.15%